← Leaderboards
Samir Kumar Gupta
Indiana Univ-Purdue Univ At Indianapolis
$7,772,068
Attributed
$14,739,707
Total exposure
19
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.1M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,739,707 · 19
By mechanism
R01$10,108,831 · 3
K12$2,913,000 · 1
R21$854,537 · 2
K23$665,709 · 1
M01$197,630 · 12
Top collaborators
- Jesse C Stewart7 shared
- Matthias Clauss5 shared
- Matthew S Freiberg4 shared
- Mervin C. Yoder2 shared
- Sheri L Robb1 shared
- Tuan Manh Tran1 shared
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Peter J Roach$18,952,824
- Mark David Pescovitz$688,057
Others in their field
Top investigators on “Resources”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$688,986,350
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Eric S Lander · Whitehead Institute For Biomedical Res$341,717,134
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$311,514,701
Research focus
ResourcesMediatingInflammationAntiretroviral TherapyEventCardiovascular DiseasesInflammatoryCardiovascular Risk FactorGeneral PopulationHiv InfectionsEnrollmentFutureFundingIndianaSourceResearch PersonnelPathway InteractionsFunctional DisorderGrantClinical ResearchInstitutionPharmaceutical PreparationsCardiovascular SystemPrograms
Grant awards (34)
HIV, Depression, and Insulin Resistance$3,096,280
R01 · FY2025 · DK · contact PI
CTSA K12 Program at Indiana University$971,000
K12 · FY2025 · TR · contact PI
CTSA K12 Program at Indiana University$971,000
K12 · FY2024 · TR · contact PI
CTSA K12 Program at Indiana University$971,000
K12 · FY2023 · TR · contact PI
Treating insomnia to reduce inflammation in HIV$192,956
R21 · FY2022 · MH · contact PI
Treating insomnia to reduce inflammation in HIV$232,581
R21 · FY2021 · MH · contact PI
HIV, Depression, and Cardiovascular Risk$712,860
R01 · FY2017 · HL · contact PI
HIV, Depression, and Cardiovascular Risk$721,761
R01 · FY2016 · HL · contact PI
HIV, Intermediate Monocytes, and Endothelial Colony Forming Cells$234,000
R21 · FY2016 · HL · contact PI
HIV, Depression, and Cardiovascular Risk$730,659
R01 · FY2015 · HL · contact PI
HIV, Intermediate Monocytes, and Endothelial Colony Forming Cells$195,000
R21 · FY2015 · HL · contact PI
HIV, Depression, and Cardiovascular Risk$741,170
R01 · FY2014 · HL · contact PI
HIV, Inflammation, and Endothelial Dysfunction$744,909
R01 · FY2012 · HL · contact PI
HIV, Inflammation, and Endothelial Dysfunction$771,965
R01 · FY2011 · HL · contact PI
HIV, Inflammation, and Endothelial Dysfunction$878,381
R01 · FY2010 · HL · contact PI
HIV, Inflammation, and Endothelial Dysfunction$900,940
R01 · FY2009 · HL · contact PI
HIV, Inflammation, and Endothelial Dysfunction$809,906
R01 · FY2008 · HL · contact PI
A PILOT STUDY OF SALSALATE IN REDUCING SYSTEMIC INFLAMMATION AND IMPROVING EN$9,314
M01 · FY2008 · RR · contact PI
A PILOT STUDY TO DETERMINE THE IMPACT ON DYSLIPIDEMIA OF THE ADDITION OF TENOFOV$3,181
M01 · FY2008 · RR · contact PI
HIV-RELATED PROTEINURIA AND ENDOTHELIAL DYSFUNCTION$2,726
M01 · FY2008 · RR · contact PI
A PILOT STUDY OF PENTOXIFYLLINE IN REDUCING SYSTEMIC INFLAMMATION AND IMPROVING$227
M01 · FY2008 · RR · contact PI
HIV-Related Proteinuria and Endothelial Dysfunction$124,712
K23 · FY2007 · HL · contact PI
A PILOT STUDY OF SALSALATE IN REDUCING SYSTEMIC INFLAMMATION AND IMPROVING EN$39,068
M01 · FY2007 · RR · contact PI
A PILOT STUDY TO DETERMINE THE IMPACT ON DYSLIPIDEMIA OF THE ADDITION OF TENOFOV$13,341
M01 · FY2007 · RR · contact PI
HIV-RELATED PROTEINURIA AND ENDOTHELIAL DYSFUNCTION$11,433
M01 · FY2007 · RR · contact PI
A PILOT STUDY OF PENTOXIFYLLINE IN REDUCING SYSTEMIC INFLAMMATION AND IMPROVING$951
M01 · FY2007 · RR · contact PI
HIV-Related Proteinuria and Endothelial Dysfunction$132,742
K23 · FY2006 · HL · contact PI
HIV-RELATED PROTEINURIA AND ENDOTHELIAL DYSFUNCTION$56,286
M01 · FY2006 · RR · contact PI
A PILOT STUDY TO DETERMINE THE IMPACT ON DYSLIPIDEMIA OF THE ADDITION OF TENO$730
M01 · FY2006 · RR · contact PI
HIV-Related Proteinuria and Endothelial Dysfunction$139,328
K23 · FY2005 · HL
HIV-RELATED PROTEINURIA AND ENDOTHELIAL DYSFUNCTION$38,924
M01 · FY2005 · RR
EFAVIRENZ, NEVIRAPINE, AND LOPINAVIR/RITONAVIR IN HIV-INFECTED SUBJECTS$21,449
M01 · FY2005 · RR
HIV-Related Proteinuria and Endothelial Dysfunction$130,045
K23 · FY2004 · HL
HIV-Related Proteinuria and Endothelial Dysfunction$138,882
K23 · FY2003 · HL